CClinicalTrials.gg
CompletedNCT02247466Updated Jul 2, 2019Results posted

Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade

A Phase 4 interventional study of Rocuronium and Sugammadex in Laparoscopic Herniotomy, sponsored by Herlev Hospital. Completed at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-02.

Sponsored by Herlev Hospital · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will act as their own control with evaluation of surgical work space and surgical conditions during both deep NMB and no NMB.

Read the detailed description

Umbilical herniotomy is a frequent surgical procedure worldwide, and the larger hernia defects are preferably operated by laparoscopic technique. The advantages of the laparoscopic approach are shorter convalescence with earlier mobilization, and less wound complications [1]. A preferred approach is currently to close the defect by laparoscopic suturing in order to reduce the formation of seroma in the hernia sac [2] , and then apply a mesh by intraperitoneal onlay technique (IPOM technique). However, it may be difficult to suture the defect if there is tension in the abdominal wall muscles together with the applied pneumoperitoneum.

There is evidence that muscle relaxation improves conditions for endotracheal intubation[3] and reduces laryngeal morbidity but only a few studies investigate the necessity of relaxation during laparoscopic surgery [4].

During laparoscopic surgery muscle relaxation is used with great variability. Sometimes the procedure is performed without muscle relaxation and sometimes with a so-called surgical neuromuscular blockade, which with objective neuromuscular monitoring means that train-of-four (TOF) is kept at 3-4 responses to nerve stimulation of the ulnar nerve. In this way there is a great variability in the neuromuscular blockade and rarely the patients are receiving deep neuromuscular blockade.

Traditionally, neuromuscular monitoring is done by measuring the muscle strength of the adductor pollicis muscle on the thumb. The response to TOF nerve stimulation may be zero, while muscle relaxation of more resistant muscles such as the abdominal muscles and the diaphragm [5;6] are not complete which means that the patients may cough and their abdominal wall may feel "tight" during surgery, even though no response at the thumb is recorded. It is possible to quantify a deep neuromuscular block by the use of post-tetanic-count (PTC). With establishment of deep, continuous neuromuscular blockade with PTC value 0-1 all muscles including abdominal muscles and diaphragm are paralyzed [7]. It is therefore possible, that a deep neuromuscular blockade (NMB) where the diaphragm and the abdominal wall muscles are more paralyzed will optimize the surgical work space, ease the surgical procedure, reduce operative time for the suturing part of the procedure as well as the total procedure time, and reduce the number of recurrences by long term follow-up.

The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will act as their own control with evaluation of surgical work space and surgical conditions during both deep NMB and no NMB.

Hypothesis:

Deep NMB defined as TOF=0 and post-tetanic count PTC ≥1, will give better surgical workspace, better surgical conditions, as well as shorter duration of surgery and reduced number of recurrences of hernias compared with no NMB.

02

Conditions studied

  • Laparoscopic Herniotomy

Keywords

  • Neuromuscular Blockade
  • Laparoscopy
03

In context

Lead sponsor

Herlev Hospital is the lead sponsor of 195 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients > 18 years old
  • Elective laparoscopic umbilical herniotomy, incisional herniotomy and linea alba - herniotomy
  • Can read and understand Danish
  • Informed consent

Exclusion criteria

Exclusion Criteria:

  • Known allergy to sugammadex, rocuronium or mivacurium
  • Known homozygous variants in the butyrylcholinesterase gene
  • Severe renal disease, defined by S-creatinine> 0.200 mmol/L, GFR \< 30ml/min or hemodialysis)
  • Neuromuscular disease that may interfere with neuromuscular data
  • Lactating or pregnant (Women of child bearing potential must take a urine pregnancy test at the day of the operation. The test will be provided by the hospital staff).
  • Indication for rapid sequence induction
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
37 participants (actual)

Study arms

  • Active comparator
    Group A - Saline, assesment, rocuronium and assesment

    Intervention after intubation and placement of trocars without NMB. Bolus of saline (placebo) 6mL (TOF 100%) the surgeon assesses the surgical workspace with pneumoperitoneum 12 mmHg. After administration of rocuronium 0.6 mg/kg when TOF=0 the surgical workspace is assessed again

    Drug: Rocuronium and Sugammadex

  • Active comparator
    Group B - Rocuronium, assesment, sugammadex and assesment

    Intervention after intubation and placement of trocars without NMB. Bolus of rocuronium 0.6 mg/kg when TOF=0 the surgeon assesses the surgical workspace with pneumoperitoneum 12 mmHg. Three minutes after administration of sugammadex (TOF 100%) the surgical workspace is assessed again

    Drug: Rocuronium and Sugammadex

Interventions

  • DrugRocuronium and Sugammadex
06

What researchers measure

Primary outcomes

  1. Improvement of Surgical Workspace

    Improvement of surgical workspace (rated on a 5-point scale) estimated as the difference between the workspace during deep NMB and the workspace without NMB. Ratings are performed in the same patient during stable pneumoperitoneum at 12 mmHg. (1 Extremely poor conditions; 2 Poor conditions; 3 Acceptable conditions; 4 Good conditions; 5 Optimal conditions)

    Time frame: 3 hours

Secondary outcomes

  1. Surgical Conditions While Suturing

    Surgeon´s rating of surgical conditions while suturing the hernia (5-point rating scale) (1 Extremely poor conditions; 2 Poor conditions; 3 Acceptable conditions; 4 Good conditions; 5 Optimal conditions)

    Time frame: 3 hours

  2. Operating Time

    Duration of operating time (from first incision to last suture)

    Time frame: 3 hours

  3. Suturing Time

    Duration of suturing the hernia (minutes)

    Time frame: 3 hours

  4. Contractions

    Sudden contractions of the abdominal wall during operation (bucking or coughing), number of participants with sudden contractions

    Time frame: 3 hours

  5. Insufflator Alarms

    Insufflator alarms where pneumoperitoneum \> 17 mmHg Number of patients experiencing insufflator alarms where pneumoperitoneum \> 17 mmHg

    Time frame: 3 hours

  6. Continuous Abdominal Contractions

    Number of patients experiencing episodes with continuous abdominal contractions where the abdomen feels "tight" but the operation can still proceed (the intestines are gradually displaced near the inner surface of the abdominal wall)

    Time frame: 3 hours

  7. Recurrences of Hernias

    Number of recurrences of hernias by 2 year follow-up (separate publication).

    Time frame: 2 years

07

Results

Posted Jul 2, 2019

Participant flow

Participant flow — Overall Study
MilestoneGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Started1918
Completed1915
Not completed03
Withdrew: Procedure changed to open surgery03

Outcome measures

PrimaryImprovement of Surgical Workspace

Improvement of surgical workspace (rated on a 5-point scale) estimated as the difference between the workspace during deep NMB and the workspace without NMB. Ratings are performed in the same patient during stable pneumoperitoneum at 12 mmHg. (1 Extremely poor conditions; 2 Poor conditions; 3 Acceptable conditions; 4 Good conditions; 5 Optimal conditions)

Time frame:
3 hours
Reported as:
Count of participants · Participants
Improvement of Surgical Workspace
ParticipantsGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Changes in ratings 5 to 301
Changes in ratings 4 to 300
Changes in ratings 5 to 404
Changes in ratings 3 to 310
Changes in ratings 4 to 412
Changes in ratings 5 to 5144
Changes in ratings 4 to 522
Changes in ratings 3 to 401
Changes in ratings 3 to 511
SecondarySurgical Conditions While Suturing

Surgeon´s rating of surgical conditions while suturing the hernia (5-point rating scale) (1 Extremely poor conditions; 2 Poor conditions; 3 Acceptable conditions; 4 Good conditions; 5 Optimal conditions)

Time frame:
3 hours
Reported as:
Count of participants · Participants
Surgical Conditions While Suturing
ParticipantsGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
1. Extremely poor conditions00
2. Poor conditions00
3. Acceptable conditions02
4. Good conditions34
5. Optimal conditions167
SecondaryOperating Time

Duration of operating time (from first incision to last suture)

Time frame:
3 hours
Reported as:
Mean · minutes
Operating Time
minutesGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Operating Time61 (37 to 85)64 (33 to 95)
SecondarySuturing Time

Duration of suturing the hernia (minutes)

Time frame:
3 hours
Reported as:
Mean · minutes
Suturing Time
minutesGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Suturing Time10 (1 to 19)9 (2 to 16)
SecondaryContractions

Sudden contractions of the abdominal wall during operation (bucking or coughing), number of participants with sudden contractions

Time frame:
3 hours
Reported as:
Count of participants · Participants
Contractions
ParticipantsGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Contractions10
SecondaryInsufflator Alarms

Insufflator alarms where pneumoperitoneum \> 17 mmHg Number of patients experiencing insufflator alarms where pneumoperitoneum \> 17 mmHg

Time frame:
3 hours
Reported as:
Count of participants · Participants
Insufflator Alarms
ParticipantsGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Insufflator Alarms00
SecondaryContinuous Abdominal Contractions

Number of patients experiencing episodes with continuous abdominal contractions where the abdomen feels "tight" but the operation can still proceed (the intestines are gradually displaced near the inner surface of the abdominal wall)

Time frame:
3 hours
Reported as:
Count of participants · Participants
Continuous Abdominal Contractions
ParticipantsGroup A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and Assesment
Continuous Abdominal Contractions00
SecondaryRecurrences of Hernias

Number of recurrences of hernias by 2 year follow-up (separate publication).

Time frame:
2 years

Results for this outcome have not been posted.

Adverse events

Collected over Patients will be observed during their stay at the hospital and will be contacted by telephone on first and seventh postoperative day. Possibly adverse events during this period will be reported. Finally the patient´s case files will be reviewed for reports of adverse events at 17-21 days after operation.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Group A - Saline, Assesment, Rocuronium and Assesment0/19 (0%)0/19 (0%)0/19 (0%)
Group B - Rocuronium, Assesment, Sugammadex and Assesment0/15 (0%)0/15 (0%)0/15 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Mean57 ± 1755 ± 1556.4 ± 15.5
Sex: Female, Male
Sex: Female, Male(Participants)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Female459
Male151025
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Count of participants——0
BMI
BMI(kg/m2)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Mean28 ± 430 ± 429 ± 4.17
ASA 1/2/3
ASA 1/2/3(Participants)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
ASA 1549
ASA 2121022
ASA 3213
Previous abdominal surgery
Previous abdominal surgery(Participants)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Count of participants121022
Herniea size (cm)
Herniea size (cm)(cm)Group A - Saline, Assesment, Rocuronium and AssesmentGroup B - Rocuronium, Assesment, Sugammadex and AssesmentTotal
Mean2.4 ± 1.53.1 ± 2.12.72 ± 1.82
08

Study locations

2 sites
  • Gentofte Hospital
    Hellerup, Region Hovedstaden 2900, Denmark
  • Herlev Hospital
    Herlev, Region Hovedstaden 2730, Denmark
09

References and documents

Publications

  • Soderstrom CM, Borregaard Medici R, Assadzadeh S, Folsgaard S, Rosenberg J, Gatke MR, Madsen MV. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study. Eur J Anaesthesiol. 2018 Nov;35(11):876-882. doi: 10.1097/EJA.0000000000000833. PubMed 29878947 ↗
  • Medici R, Madsen MV, Asadzadeh S, Folsgaard S, Rosenberg J, Gatke MR. Neuromuscular blockade during laparoscopic ventral herniotomy: protocol for a randomised controlled trial. Dan Med J. 2015 Aug;62(8):A5120. PubMed 26239595 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 16, 2016

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02247466
Lead sponsor
Herlev Hospital
Responsible party
Roar Medici (MD, research assistant, Herlev Hospital) — Principal investigator
First posted
Sep 25, 2014
Start date
Feb 2015
Primary completion
Feb 23, 2017
Completion
Feb 23, 2017
Results posted
Jul 2, 2019
Last update
Jul 2, 2019

Study contacts

Mona Ring Gätke, MD, Ph.D.
study chair · Department of Anaesthesiology, Herlev Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion